- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x JUQ: (1~{S},2~{S})-2-[5-[cyclopropylmethyl(naphthalen-1-yl)amino]-4-methoxy-pyrimidin-2-yl]carbonylcyclopropane-1-carboxylic acid(Non-covalent)
- 2 x NI: NICKEL (II) ION(Non-covalent)
NI.2: 6 residues within 4Å:- Chain A: H.6, H.8
- Chain B: H.6, H.8
- Chain C: H.6, H.8
6 PLIP interactions:2 interactions with chain B, 2 interactions with chain A, 2 interactions with chain C- Metal complexes: B:H.6, B:H.8, A:H.6, A:H.8, C:H.6, C:H.8
NI.10: 2 residues within 4Å:- Chain C: H.3, H.5
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:H.3, C:H.5
- 9 x PLM: PALMITIC ACID(Non-covalent)
PLM.3: 4 residues within 4Å:- Chain A: W.123, L.124, A.127, A.130
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:W.123, A:W.123, A:L.124, A:A.127, A:A.130
PLM.4: 1 residues within 4Å:- Chain A: W.123
No protein-ligand interaction detected (PLIP)PLM.5: 2 residues within 4Å:- Chain A: P.139, R.143
No protein-ligand interaction detected (PLIP)PLM.6: 7 residues within 4Å:- Chain A: H.8, E.11, W.75, I.79
- Chain C: L.71, W.75
- Ligands: PLM.7
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain C- Hydrophobic interactions: A:H.8, A:I.79, C:L.71, C:W.75, C:W.75, C:W.75
PLM.7: 9 residues within 4Å:- Chain A: H.7, H.8, L.71, W.75
- Chain B: E.11, W.75, I.79
- Ligands: PLM.6, PLM.13
6 PLIP interactions:4 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:L.71, A:W.75, A:W.75, B:W.75, B:I.79
- Hydrogen bonds: A:H.8
PLM.11: 5 residues within 4Å:- Chain B: A.17, L.20
- Chain C: A.130, L.134, F.137
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain C- Hydrophobic interactions: B:A.17, C:F.137, C:F.137
PLM.12: 1 residues within 4Å:- Chain C: P.139
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:P.139
PLM.13: 8 residues within 4Å:- Chain B: H.7, H.8, L.71, W.75
- Chain C: E.11, W.75, I.79
- Ligands: PLM.7
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:L.71, B:W.75, B:W.75
- Hydrogen bonds: B:H.8
PLM.14: 3 residues within 4Å:- Chain C: W.123, L.124, A.127
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:W.123, C:W.123, C:L.124
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Munck Af Rosenschold, M. et al., Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma. J.Med.Chem. (2019)
- Release Date
- 2019-08-28
- Peptides
- Leukotriene C4 synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
JB
KC
L - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x JUQ: (1~{S},2~{S})-2-[5-[cyclopropylmethyl(naphthalen-1-yl)amino]-4-methoxy-pyrimidin-2-yl]carbonylcyclopropane-1-carboxylic acid(Non-covalent)
- 2 x NI: NICKEL (II) ION(Non-covalent)
- 9 x PLM: PALMITIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Munck Af Rosenschold, M. et al., Discovery of the Oral Leukotriene C4 Synthase Inhibitor (1S,2S)-2-({5-[(5-Chloro-2,4-difluorophenyl)(2-fluoro-2-methylpropyl)amino]-3-methoxypyrazin-2-yl}carbonyl)cyclopropanecarboxylic Acid (AZD9898) as a New Treatment for Asthma. J.Med.Chem. (2019)
- Release Date
- 2019-08-28
- Peptides
- Leukotriene C4 synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
JB
KC
L - Membrane
-
We predict this structure to be a membrane protein.